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Introduction
Peroxisomes (POs) are multifunctional organelles that play piv-
otal roles in the metabolism of lipids and reactive oxygen species 
and are essential for human health and development (Wanders 
and Waterham, 2006; Nordgren and Fransen, 2014). These 
functions require a dynamic spatial organization that permits 
exchange of metabolites and signals with other organelles such 
as the ER, mitochondria, lipid droplets, and lysosomes (Chu 
et al., 2015; Gao and Goodman, 2015; Schrader et al., 2015b). 
POs collaborate extensively with the ER in the biosynthesis of 
ether-phospholipids (e.g., myelin sheath lipids) and polyunsat-
urated fatty acids, and defects in these pathways are linked to 
neurodegenerative disorders (Wanders and Poll-The, 2015). Fur-
thermore, the ER is involved in PO biogenesis, likely playing a 
role in the delivery of phospholipids to PO (Raychaudhuri and 
Prinz, 2008; Hettema et al., 2014). In ultrastructural studies, POs 
are often found apposed to ER tubules (Novikoff and Shin, 1964) 
with short electron-dense cross-bridges between isolated POs and 
associated ER, suggesting an intimate, physical interaction (Zaar 
et al., 1987). Despite the decades that have passed since PO–ER 
associations were first observed, we still know little about their 
formation, structure, and function. In yeast, the EPC ON (ER–
PO contact) complex and an PO–ER junction complex involving 
Pex3 and Inp1p required for PO inheritance have been reported, 
but analogous systems in higher eukaryotes have not been identi-
fied (David et al., 2013; Knoblach et al., 2013).
Here, we identify the PO membrane protein acyl-coenzyme 
A–binding domain protein 5 (ACBD5) as a binding partner for 
the ER protein VAPB (vesicle-associated membrane protein- 
associated protein B). We show that ACBD5–VAPB interaction 
regulates PO–ER associations, the loss of which perturbs PO 
membrane expansion and increases PO motility. Our findings 
reveal the first molecular mechanism for establishing PO–
ER associations in mammalian cells and a new function for 
ACBD5 in PO–ER tethering.
Results and discussion
Peroxisomal ACBD5 is a binding partner 
for ER-resident VAPB
Previous studies identified ACBD5 in highly purified PO frac-
tions and revealed its exclusive PO localization (Islinger et al., 
2007; Wiese et al., 2007; Nazarko et al., 2014). To identify po-
tential binding partners of ACBD5, we expressed GFP-ACBD5 
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in HepG2 cells and performed pull-down studies and mass spec-
trometry (MS) analysis. Results from three independent experi-
ments identified the ER membrane protein VAPB as a candidate 
binding partner (Table 1 and Fig. 1 A). In two out of three ex-
periments, we also found enrichment of the closely related pro-
tein VAPA (Table 1). ACBD5–VAPB binding was confirmed by 
immunoprecipitation (IP) after coexpression of GFP-ACBD5 
and Myc-VAPB in COS-7 cells (Fig. 1 B). A direct interaction 
between ACBD5 and VAPB was shown by expressing recombi-
nant versions in Escherichia coli and performing in vitro bind-
ing assays (Fig. 1 C). Additionally, in a genome-wide protein 
interaction screen, ACBD5 was among proteins identified as 
potential VAPB interaction partners (Huttlin et al., 2015).
VAPB is a tail-anchored ER membrane protein, which 
functions as an adaptor in interorganellar lipid exchange and 
membrane tethering (Lev et al., 2008). VAPB interactions are 
mediated by its MSP domain (Fig.  1  A), which recognizes 
FFAT-like motifs (two phenylalanines [FF] in an acidic tract), 
one of which has recently been predicted in ACBD5 (Murphy 
and Levine, 2016). In line with this, VAPB–ACBD5 interaction 
was lost when critical residues in the FFAT-like motif were mu-
tated (Fig. 1 C). In contrast, VAPB–ACBD5 interaction was still 
observed after mutating residues in the ACBD5 acyl-coenzyme 
A–binding domain (AcB), shown to abolish acyl-coenzyme 
A (acyl-CoA) binding (Kragelund et al., 1999; Nazarko et al., 
2014). We conclude that VAPB and ACBD5 interact directly via 
the ACBD5 FFAT-like motif (Fig. 1 D).
ACBD5 and VAPB mediate PO–ER 
associations
As VAPB is involved in ER–organelle associations (Lev et al., 
2008; Peretti et al., 2008; Stoica et al., 2014), we hypothesized 
that ACBD5 and VAPB act as tethers linking the ER with POs. 
To test this, we expressed Myc-VAPB and/or GFP-ACBD5/
FLAG-ACBD5 in COS-7 cells and monitored PO–ER colo-
calization by confocal microscopy (Fig. 2). POs are usually in 
close proximity to the ER (Novikoff and Shin, 1964) but never 
fully overlap with ER markers (Fig.  2, Sec61β). When both 
VAPB and ACBD5 were coexpressed, increased association 
of PO with Myc-VAPB-labeled ER was observed (Fig. 2, B 
and C). Remarkably, coexpression allowed visualization of 
discrete PO structures using the ER marker VAPB (compare 
arrows in Fig. 2, A and B), suggesting these POs are in close 
contact with the ER. This characteristic PO–ER association was 
still observed when VAPB was coexpressed with the ACBD5-
AcB mutant (Fig. 2 D), but not after coexpression with the 
ACBD5 FFAT mutant (Fig.  2  E). Although coexpression of 
ACBD5 with the ER protein Sec61β slightly increased PO–ER 
overlay (Fig.  2  G), characteristic PO–ER associations were 
not evident (Fig.  2  F). Quantification of fluorescence signals 
indicated a slight increase in PO–ER overlap when ACBD5 
or VAPB was expressed individually, but overlap was high-
est after coexpression (Fig.  2  G). In line with this, a mutant 
ACBD5 localizing to mitochondria increased association of 
mitochondria with VAPB-labeled ER (Fig. S1). These find-
ings support a role for ACBD5 and VAPB in PO–ER tether-
ing, which we further investigated using ultrastructural and 
biochemical approaches.
To quantify PO–ER associations at the ultrastructural 
level, we performed transmission EM with COS-7 cells ex-
pressing FLAG-ACBD5, Myc-VAPB, or FLAG-ACBD5/Myc-
VAPB (Fig.  3  A). We quantified PO–ER associations using 
unbiased spatial stereology to (a) determine the mean popula-
tion of POs in close contact (<15 nm) with the ER (Fig. 3 B, 
mean attachment) and (b) estimate the proportion of the PO 
surface closely apposed (<15 nm) to the ER (Fig. 3 C, mean 
ER contact). A similar approach using manual tracing soft-
ware was used by others (Cosson et al., 2012; Stoica et al., 
2014). When ACBD5 and VAPB were coexpressed, the mean 
population of PO associated with the ER increased signifi-
cantly (89.35 ± 0.69% vs. 66.17 ± 2.63% in controls; Fig. 3 B), 
and the mean ER contact doubled (Fig. 3 C). Both the mean 
PO–ER attachment and mean ER contact were also slightly 
increased in cells expressing VAPB or ACBD5 alone (Fig. 3, 
A–C). Coexpression of VAPB with the ACBD5-AcB mutant 
was comparable to wild-type, whereas coexpression with the 
ACBD5-FFAT mutant resulted in a significantly lower in-
crease in both mean ER contact and PO–ER attachment (Fig. 3, 
B and C; and Fig. S2).
PO–ER associations were confirmed by immunogold-EM 
of COS-7 cells expressing a GFP-PO targeting signal 1 fusion 
(GFP-PTS1), which targets the PO matrix. Cells were mock-
treated or cotransfected with ACBD5/VAPB and PO identified 
by anti-GFP antibodies (Fig. S2). In control cells, globular POs 
were mainly located in close vicinity to the ER (Fig. S2). In 
cotransfected cells ER membranes were tightly associated with 
GFP-labeled PO, often covering large portions of the PO sur-
face. Electron-dense structures were visible between the ER 
and PO membranes, appearing to tether ER with PO (Fig. S2 
and Fig. 3 A). The space between ER and PO in cotransfected 
cells was <15 nm, similar to that observed in other organelle 
membrane associations (Prinz, 2014).
Similar results regarding PO–ER association were ob-
tained with HepG2 cells (Fig. S2). Here, we silenced ACBD5 
and/or VAPB and quantified PO–ER associations by transmis-
sion EM (Fig.  3, D–F). Using siRNAs, ACBD5 and VAPB 
expression was efficiently reduced, without one influencing 
expression of the other (Fig. 3 G). In controls, 82.40 ± 1.09% 
of POs were in close contact with the ER, and 27.35 ± 0.77% 
of the PO surface was closely associated with the ER. Knock-
down of either ACBD5 or both ACBD5 and VAPB significantly 
reduced the fraction of POs associated with the ER (ACBD5: 
Table 1. Identification of VAPB and VAPA by MS after coimmunoprecipitation with GFP-ACBD5 from HepG2 cells
Accession number Gene name Mass Coverage, 
maximum
Matched peptides, 
maximum
Unique peptides, 
maximum
ACBD5/control ratio, 
average
Number of  
experiments detected
D %
Q528D3 ACBD5 60,092 16.0 8 8 >10 3/3
O95292 VAPB 27,228 51.4 16 14 4.8 3/3
A8KA83 VAPA 27,318 47.9 20 18 7.7 2/3
Results from three experiments. GFP was used as a control. Protein abundance was quantified by label-free peptide counting.
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57.85 ± 1.76%; ACBD5 + VAPB: 49.45 ± 3.45%) and the mean 
ER contact (ACBD5: 14.52 ± 1.0%; ACBD5 + VAPB: 9.62 ± 
0.82%; Fig.  3, D–F). Knockdown of VAPB alone had only a 
minor effect (Fig. 3, E and F). This may be explained by the 
ability of ACBD5 to interact with other proteins such as the 
functionally similar VAPA (Table 1; Murphy and Levine, 2016).
To confirm the morphological results by biochemical 
analyses, we separated POs from HepG2 cells using a combina-
tion of differential and Nycodenz gradient centrifugation. Gra-
dient fractions were collected from untransfected cells and cells 
cotransfected with Myc-VAPB and GFP-ACBD5 (Fig.  4  A). 
POs in control gradients were well separated from mitochondria 
and migrated to higher densities than microsomes (PO fractions 
2 and 3 vs. 4 and 5 for ER; Fig. 4 A). When ACBD5 and VAPB 
were coexpressed, POs and microsomes partially comigrated, 
showing comparable maxima for marker proteins (fraction 
5; Fig.  4 A). These findings suggest a tighter association be-
tween both organelles in cells coexpressing ACBD5 and VAPB, 
creating PO–ER structures with altered buoyant densities, sup-
porting a role for ACBD5 and VAPB in PO–ER association.
Silencing of ACBD5 increases 
PO movements
Next, we investigated if an ACBD5-dependent PO–ER asso-
ciation would affect PO motility. Fibroblasts were cotrans-
fected with GFP-PTS1 and ACBD5 siRNA (Fig. 4, B–H; and 
Videos 1 and 2), and PO motions recorded in individual cells. 
No differences in PO movements between untreated cells 
and those treated with control siRNA were observed. In con-
trast, silencing of ACBD5 resulted in a prominent increase of 
PO movements (Video 2). To measure movement, POs were 
automatically detected and tracked using a customized in-
house algorithm. The trajectories of 100 randomly sampled 
POs were plotted to visualize displacements from a central 
point (Fig.  4, B–D). Displacements increased when ACBD5 
was silenced. To extend this analysis, the displacements of 
Figure 1. ACBD5 interacts with VAPB. (A) Schematic 
overview of VAPB and ACBD5 domain structure. Mu-
tations in acyl-CoA binding and FFAT-like motifs are 
indicated. (B) Immunoprecipitation (IP) of GFP-ACBD5 
and Myc-VAPB after coexpression in COS-7 cells. GFP 
was used as control. Samples were immunoprecipi-
tated (GFP-Trap) and immunoblotted using Myc-GFP 
antibodies. (C) In vitro binding assay using GST-VAPB 
and MBP fusions of ACBD5 (AcB, mutations in the 
acyl-CoA binding motif; FFAT, mutations in FFAT motif) 
expressed in E. coli. GST served as control. Samples 
were immunoprecipitated using GST-Trap and immu-
noblotted using MBP-GST antibodies. (D) Model of 
ACBD5–VAPB interaction.
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all POs from each experimental group were plotted as a 2D 
histogram (Fig. 4, E–G). In agreement with the first analysis, 
PO displacement was clearly increased after ACBD5 knock-
down. Fig. 4 H displays the empirical cumulative distribution 
function (ECDF) of the instantaneous PO speeds for each ex-
perimental condition. This shows the distribution of the total 
population of POs, with each point of the curve correspond-
ing to a single movement. A significant increase in the num-
ber of moving POs can be observed in ACBD5-silenced cells 
(mean speed, 100 ± 6 nm/s vs. 70 ± 3 nm/s in controls; ***, 
P ≤ 0.001; Student’s t test). These findings further support a 
role for ACBD5 in attaching POs to the ER, which appears 
to restrict PO movement.
A role for ACBD5–VAPB in PO 
membrane dynamics
PO can form by growth and division of preexisting organelles 
(Schrader et al., 2015a). A key protein in this process is Pex11β, 
which deforms and elongates the PO membrane and activates 
the GTPase DRP1 for membrane scission (Schrader et al., 1998; 
Koch et al., 2003; Delille et al., 2010; Williams et al., 2015). 
DRP1 is recruited to POs by the membrane adaptors Mff and 
Fis1 (Koch et al., 2005; Gandre-Babbe and van der Bliek, 2008; 
Otera et al., 2010). Loss of Mff results in highly elongated POs 
(and mitochondria), which are unable to divide (Shamseldin et 
al., 2012; Koch et al., 2016; Fig. 5 A). As elongation and growth 
of the PO membrane requires lipids, likely provided by the ER 
in a nonvesicular pathway (Raychaudhuri and Prinz, 2008), the 
pronounced PO elongation observed after loss of Mff suggests 
a constant transfer of lipids from the ER to POs. We hypoth-
esized that this lipid transfer is mediated by PO–ER contacts. 
To investigate a role for ACBD5–VAPB in this process, we si-
lenced ACBD5 or VAPB in patient fibroblasts deficient in Mff 
(Fig. 5). Reintroduction of Mff into nonsilenced cells resulted 
in formation of numerous spherical POs, restoring the normal 
phenotype (Fig. 5 B). Although knockdown of Pex11β had no 
effect, remarkably, silencing of ACBD5, and to a lesser extent 
VAPB, reduced membrane expansion, resulting in formation of 
Figure 2. ACBD5–VAPB coexpression increases PO–ER association. (A–F) COS-7 cells were transfected with Myc-VAPB alone (A) or Myc-VAPB coex-
pressed with GFP-ACBD5, FLAG-ACBD5, FLAG-ACBD5-AcB, FLAG-ACBD5-FFAT, and GFP-Sec61β (B–F). Myc-VAPB is labeled in red and Pex14/ACBD5 
in green, except in F, where ACBD5 is in red (B–D, arrows highlight PO–ER association; A, E, and F, arrows highlight lack of PO–ER association). 
(G) Quantification of overlap of PO–ER fluorescent signals. Note this analysis has limitations because of the proximity of POs and the ER. αPEX14, PO 
marker. Data are presented as mean ± SEM. Bars: (main) 20 µm; (insets) 5 µm.
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Figure 3. ACBD5 and VAPB mediate PO–ER association. (A) Representative electron micrographs of PO–ER associations in COS-7 cells transfected with 
control vector, ACBD5, VAPB, and ACBD5 + VAPB (arrowheads highlight close ER–PO association). Electron-dense material between the PO–ER mem-
branes is visible (see arrows in enlargement). (B) Quantitative analysis of the mean fraction of POs associated with the ER. (C) Assessment of the mean PO 
membrane surface in direct contact with the ER membrane. (D) Representative electron micrographs of PO–ER associations in HepG2 cells treated with 
control, ACBD5, VAPB, and ACBD5 + VAPB siRNAs. Arrowheads in overview mark POs with limited or no ER contact. (E) Quantitative analysis of mean 
fraction of POs associated with the ER after siRNA treatments. (F) Assessment of mean PO–ER membrane contact after siRNA treatment. (G) Immunoblot 
showing ACBD5 and VAPB signals after silencing with correspondent siRNAs. GAP DH, loading control. Data were analyzed by one-way analysis of vari-
ance with Tukey’s multiple comparison test; ns, not significant; **, P ≤ 0.01; ***, P ≤ 0.001. Error bars represent SEM, with three to six experiments per 
condition. Bars: (main) 200 nm; (zoom) 50 nm. M, mitochondrion; N, nucleus.
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Figure 4. ACBD5/VAPB interaction influences PO migration in gradients and PO motility in human fibroblasts. (A) ACBD5/VAPB coexpression alters PO 
distribution in density gradients. PO-enriched fractions, prepared from HepG2 cells (Control) and cells cotransfected with GFP-rACBD5 and Myc-VAPB, 
were separated in continuous Nycodenz-gradients. Distribution of organelle markers was assessed by immunoblotting of fractions. Coexpression of ACBD5 
and VAPB shifts POs to lower densities, similar to ER markers (compare boxed regions). Pex14 (PO); ACOX1, acyl-CoA oxidase 1 (PO); ATP synt. a, ATP 
synthase α subunit (MITO); PDI, protein disulfide isomerase (ER). (B–H) Loss of ACBD5 increases PO movement. Human fibroblasts were treated with control 
(Cont) or ACBD5 siRNA, transfected with GFP-PTS1, and analyzed by live cell imaging (Videos 1 and 2). (B–D) Trajectory plots. 100 PO trajectories were 
retrieved for each condition and the first 20 time frames plotted starting at a center. (E–G) Density plots. The x and y coordinates of all trajectories ≥20 
time frames were pooled and binned in the interval −3,3 µm in x and y directions, using 50 bins. The log-scaled 2D histogram of these points was plotted 
using “jet” color map. (H) ECDF plots. Instantaneous trajectory speed profiles were estimated by calculating distance moved between each time point in the 
trajectory. These speeds were pooled and converted to an empirical cumulative distribution function (ECDF). By pooling speeds for all datasets for a given 
condition, a single ECDF was generated for each (minimum of 38,175 trajectories from 24 videos per condition).
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shorter PO membrane tubules and spherical organelles (Fig. 5, 
C–F). To confirm the alterations were caused by membrane ex-
pansion, we quantified the size of PO membranes using EM and 
observed a significant reduction in mean PO membrane circum-
ference when comparing ACBD5-silenced cells with controls 
(Fig. S3). This effect was PO specific, as ACBD5 silencing had 
no impact on the elongated morphology of mitochondria (Fig. 
S3). Finally, expression of an artificial PO–ER tether restored 
membrane expansion after ACBD5 silencing and caused hyper-
elongation of POs in Mff-deficient fibroblasts (Fig. S3).
As POs in Mff-deficient cells are division incompetent, 
ACBD5 siRNA-mediated alterations in PO morphology are 
unlikely to result from PO membrane fission, which would 
increase PO abundance as shown for reintroduction of Mff. 
We also localized endogenous ACBD5 in Mff-deficient cells 
(Fig. 5, H–J; and Fig. S3). ACBD5 was predominantly located 
at globular PO membrane domains, which gave rise to tubular 
membrane extensions. This corroborates previous findings (De-
lille et al., 2010) and is further exemplified in cells silenced for 
ACBD5, where any residual ACBD5 is found at globular do-
mains of elongated POs (Fig. 5, K–M). In contrast to ACBD5, 
Pex11β distributes mainly to tubular PO extensions (Delille 
et al., 2010). We thus assume a direct role for ACBD5 in PO 
fission is unlikely and suggest that loss of PO–ER association 
impacts PO membrane elongation, likely because of reduced 
transfer of membrane lipids. PO membrane biogenesis requires 
lipid transfer from the ER, likely using a nonvesicular pathway 
(Raychaudhuri and Prinz, 2008). Organelle tethering can facili-
tate lipid transfer (Prinz, 2010), although the exact mechanisms 
and what drives lipid transfer are unknown. Based on data from 
other membrane contact studies, additional lipid-transfer pro-
teins are likely involved (Lev, 2010). In addition to lipid transfer 
for membrane proliferation, the PO–ER tether could also facil-
itate metabolic cooperation in the biosynthesis of ether phos-
pholipids and polyunsaturated fatty acids, which require dual 
PO–ER activity (Shai et al., 2015).
We show here that association of PO and ER is mediated 
by interaction of the PO membrane protein ACBD5 and the 
ER protein VAPB. Both proteins are anchored in the respective 
organelle membrane via a C-terminal transmembrane domain 
with N termini projecting into the cytoplasm (Fig. 1 D). VAPB 
is known to mediate ER–organelle contacts (Lev et al., 2008), 
making VAPB and ACBD5 plausible candidates for mediating 
PO–ER interactions. Several lines of evidence support this: 
Figure 5. Loss of ACBD5 or VAPB reduces 
PO membrane expansion in Mff-deficient fi-
broblasts. PO morphology in Mff-deficient 
fibroblasts (control; A) after reintroduction of 
Mff (B) or silencing of Pex11β (C), ACBD5 
(D), or VAPB (E). Fixed cells were labeled with 
anti-Pex14 antibodies. (F) Quantification of 
PO morphology in controls and silenced cells 
(n = 2,500, from three independent experi-
ments). Data are presented as mean ± SEM. 
***, P < 0.001; ns, not significant. (G) Immu-
noblots of cell lysates. Loading controls used 
were catalase (Cat), GAP DH, and thioredoxin 
(Thiored). (H–M) Localization of endogenous 
ACBD5 in Mff-deficient fibroblasts. Fixed cells 
labeled with anti-ACBD5 and anti-catalase an-
tibodies. Arrowheads denote ACBD5 concen-
trated at globular POs that give rise to tubular 
membranes. Bars, 10 µm.
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(a) ACBD5 and VAPB directly interact in IP assays via a 
FFAT-like motif in ACBD5; (b) ACBD5 and VAPB coexpres-
sion increases PO–ER associations in morphological and bio-
chemical studies, and ACBD5 and VAPB knockdown results 
in reduced PO–ER interactions; (c) loss of ACBD5 increases 
PO movements; and (d) loss of ACBD5 or VAPB perturbs PO 
membrane expansion. In conclusion, our findings reveal the 
first molecular mechanism for establishing PO–ER associa-
tions in mammalian cells.
Recently, a role for ACBD5 and its fungal orthologue, 
ATG37, in phagophore formation during pexophagy was sug-
gested (Nazarko et al., 2014). Here, we reveal a novel function 
in PO–ER tethering. ACBD5 can also interact with activated 
fatty acids, pointing toward a role in lipid metabolism. We show 
the acyl-CoA–binding domain is not essential for PO–ER teth-
ering, although we cannot exclude a role in modulating the in-
teraction. As POs and the ER cooperate in lipid metabolism, it is 
intriguing to speculate that ACBD5 fulfills multiple functions, 
coordinating PO–ER lipid transfer with PO lipid metabolism 
and biogenesis and turnover.
Both ACBD5 and VAPB are linked to neuropathological 
disorders (Kim et al., 2010; Abu-Safieh et al., 2013). Mutations 
in VAPB cause a dominantly inherited form of amyotrophic lat-
eral sclerosis. Thus, dysregulation of the PO–ER associations 
described here may contribute to some pathological features of 
amyotrophic lateral sclerosis or other neurodegenerative disor-
ders. Therefore, information on the underlying mechanisms of 
the PO–ER association could be important for understanding 
pathogenic processes in disease states. The results described 
here, which show that ACBD5 and VAPB mediate PO–ER as-
sociations, will facilitate future studies on the role of PO–ER 
associations in several processes, including lipid metabolism, 
phospholipid exchange, PO biogenesis, and autophagy.
Materials and methods
Plasmids and antibodies
For initial cloning of human genes, total RNA was extracted from 
HepG2 cells using TRIzol reagent, reverse transcribed into cDNA, and 
used as a PCR template. The artificial PO–ER tether (PO-mRFP-ER) 
was generated based on a previously published MITO-ER tether (Csor-
dás et al., 2006). The MITO-ER tether contains an N-terminal MITO 
targeting signal from AKAP1 fused to mRFP with a C-terminal ER 
localization signal for yeast UBC6. In the PO-ER tether, the N-terminal 
MITO targeting signal was replaced with the N-terminal 44 residues of 
human Pex3, which has been shown to be sufficient for PO targeting 
(Fransen et al., 2001). See Table S1 for details of plasmids used in 
this study, Table S2 for plasmids generated in this study, and Table S3 
for details of primers used. Site-directed mutagenesis to generate point 
mutations was done using the QuikChange Site-Directed Mutagenesis 
kit (Agilent Technologies). All constructs were confirmed by sequenc-
ing (Eurofins Genomics). Details on siRNA used in this study can be 
found in Table S4. Details on antibodies can be found in Table S5.
Cell culture and transfection
COS-7 (African green monkey kidney cells, CRL-1651; ATCC), HepG2 
(human hepatoblastoma cells, HB-8065; ATCC), Mff-deficient (pro-
vided by F.S. Alkuraya, King Faisal Specialist Hospital and Research 
Center, Riyadh, Saudi Arabia), and human control (C109) fibroblasts 
(provided by H. Waterham, Academic Medical Center, University of 
Amsterdam, Amsterdam, Netherlands) were cultured in DMEM, high 
glucose (4.5  g/l) supplemented with 10% FBS, 100 U/ml penicillin, 
and 100 µg/ml streptomycin at 37°C with 5% CO2 and 95% humidity. 
COS-7 and HepG2 cells were transfected using diethylaminoethyl-dex-
tran (Sigma-Aldrich) or Lipofectamine (Invitrogen, Thermo Fisher Sci-
entific). Fibroblasts were transfected by microporation using the Neon 
Transfection System (Thermo Fisher Scientific) following the man-
ufacturer’s protocol. In short, cells (seeded 24 h before transfection) 
were washed once with PBS and trypsinized using TrypLE Express. 
Trypsinized cells were resuspended in complete medium, pelleted by 
centrifugation, and washed with PBS. The cells were once again centri-
fuged and carefully resuspended in 110 µl buffer R. For each condition, 
4 × 105 cells were mixed with the DNA construct (5–10 µg) or with 
50–100 nM siRNA (Table S4). Cells were microporated using a 100 µl 
neon tip with the following settings: 1,400 V, 20 ms, one pulse. Mi-
croporated cells were immediately seeded into plates with prewarmed 
complete medium without antibiotics and incubated at 37°C with 5% 
CO2 and 95% humidity. Cell lysates to monitor efficiency of silencing 
were prepared as described under IP.
Immunofluorescence and microscopy
Cells were processed for immunofluorescence 24 or 48 h after transfec-
tion. Cells grown on glass coverslips were fixed with 4% paraformal-
dehyde in PBS, pH 7.4, permeabilized with 0.2% Triton X-100, and 
incubated with primary and secondary antibodies as described previ-
ously (Bonekamp et al., 2013; Table S5). Cell imaging was performed 
using an IX81 microscope (Olympus) equipped with an UPlanSApo 
100×/1.40 oil objective (Olympus). Digital images were taken with a 
CoolSNAP HQ2 CCD camera and adjusted for contrast and brightness 
using the Olympus Soft Imaging Viewer software and MetaMorph 7 
(Molecular Devices). Confocal images were obtained using a Leica 
Biosystems SP8 equipped with an argon laser (488 nm), a DPSS561 
laser (561 nm), an HC PL APO 63×/1.3 oil objective, an HC PL APO 
100×/1.44 oil objective, and hybrid detectors.
Analyses of PO–ER fluorescence overlap were performed using 
a custom Python implementation of Pearson and Manders colocal-
ization measures, which used the Numpy and Scikit image libraries 
(van der Walt et al., 2011, 2014) In brief, after loading, images were 
split into red and green channels. Cell regions of interest were man-
ually defined, and Otsu thresholding was used to calculate percent-
age of overlap of foreground pixels and the Pearson and Manders 
colocalization measures.
For live-cell imaging, fibroblasts were cotransfected with GFP-
PTS1 and ACBD5 siRNA 48 h before imaging and plated in 3.5-cm- 
diameter glass bottom dishes (Cellview; Greiner BioOne). Before 
image acquisition, a controlled-temperature chamber was set-up on the 
microscope stage at 37°C, as well as an objective warmer. During image 
acquisition, cells were kept at 37°C and in CO2-independent medium 
(Hepes buffered). For fibroblasts, 250 stacks of nine planes (0.5-µm 
thickness and 100-ms exposure) were taken in a continuous stream. All 
conditions and laser intensities were kept between experiments. Live-
cell imaging data were collected using an IX81 microscope equipped 
with a CSUX1 spinning disk head (Yokogawa), CoolSNAP HQ2 CCD 
camera, and 60×/1.35 oil objective. Digital images were taken and pro-
cessed using VisiView software (Visitron Systems).
PO motility measurements
POs were automatically detected and tracked using a customized in-
house algorithm. In brief, each image was filtered using a scale-space 
Laplace of Gaussian filtering approach (Lindeberg, 1994, 1998) over 
scales corresponding to the size range of POs. After filtering, a thresh-
old was determined using the median absolute deviation as a robust 
estimator of the background level (Murtagh and Starck, 2000) and 
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applied to the filtered image to segment POs. Once detected, POs were 
tracked using a global optimization solution to the linear assignment 
problem using a modified version of the Jonker–Volgenant algorithm 
(Jonker and Volgenant, 1987). Tracking results were manually verified 
for accuracy. For PO trajectory plots, 100 trajectories were retrieved 
for each condition by randomly selecting approximately four trajec-
tories at least 20 time frames long from each dataset. Next, the tra-
jectories were centered such that each trajectory started at (0,0) and 
subsequently smoothed applying a simple moving-mean algorithm 
using a Hann window. The first 20 points along these trajectories were 
then plotted. For density plots, all trajectories of at least 20 time frames 
were smoothed as described for the trajectory plots, and subsequently, 
the x and y coordinates of the centered trajectories were pooled and 
binned in the interval −3,3 µm in both x and y directions, using 50 bins, 
corresponding to a bin width of 0.12 µm. The log-scaled 2D histogram 
of these points using the aforementioned bins was plotted using the 
“jet” color map. For ECDF plots, instantaneous trajectory speed pro-
files were estimated by calculating the distance moved between each 
time-point in the trajectory. These speeds were then pooled and con-
verted into an ECDF. By pooling the speeds for all datasets for a given 
condition a single ECDF for each condition was generated.
EM and spatial stereology
For transmission EM, monolayers of COS-7, HepG2 cells and Mff- 
deficient human skin fibroblasts were fixed in 0.5% glutaraldehyde in 
0.2 M Pipes buffer, pH 7.2, for 15 min at room temperature. Cells were 
then scraped from the culture dish in a small volume of the fixative 
before pelleting (10 min at 17,000  g). After three washes in buffer, 
the cell pellet was fragmented and postfixed for 1  h in 1% osmium 
tetroxide (reduced with 1.5% wt/vol potassium ferrocyanide) in 0.1 M 
sodium cacodylate buffer, pH 7.2. After a series of washes in distilled 
water (3 × 5 min), the pellet fragments were dehydrated through an 
ethanol gradient and embedded in Durcupan resin (Sigma-Aldrich). 
80-nm ultrathin sections were collected on pioloform-coated 100-mesh 
copper EM grids (Agar Scientific) and contrasted with lead citrate be-
fore imaging using a JEOL JEM 1400 transmission electron micro-
scope operated at 120 kV. For quantification of the extent of PO–ER 
surface contacts, POs were sampled (n = 38–64 POs per experimental 
condition and grid; mean of 47) by scanning the EM grids systematic 
uniform random (SUR) and imaging of positively identified PO profiles 
within the scanning band at a nominal magnification of 80,000 using a 
digital camera (ES 100W CCD; Gatan). SUR sampling ensured unbi-
ased selection of profiles from the total population of cells regardless 
of being transfected or nontransfected. Organelle profiles were iden-
tified as POs by the presence of a single membrane, a homogenous 
fine-granular matrix, and profile size. Sampled PO profiles had sizes 
between 259.92 ± 13.55 nm and 234.99 ± 10.74 nm along the longest 
axis and 150.28 ± 5.78 nm and 123.72 ± 3.83 nm along the shortest 
axis in HepG2 and COS-7 cells, respectively (for sizing, n = 50 POs 
per cell line; error = SEM). The morphology and size of sampled POs 
was similar to POs labeled with GFP-PTS1 by immunogold EM. To 
estimate the mean fraction of total PO membrane surface in direct con-
tact with the ER, a stereological approach by line intersection counting 
was used (Weibel, 1979). SUR sampled micrographs were opened in 
Photoshop CS6, positioned randomly in relation to a square lattice grid 
(line spacing 184 nm), and intersections with PO membranes counted. 
Intersections were classified as direct membrane contact (defined as 
“attachment” in Fig. 3 B) if there was <15 nm distance between PO 
and ER membranes (yielding between 135 and 335 total intersection 
counts per experiment). The mean PO membrane circumference in 
Mff-deficient fibroblasts was also estimated by line intersection count-
ing on SUR sampled PO profiles as described for the measurement of 
the mean fraction of total membrane surface (n = 53–75 POs [mean of 
61] and 178–556 total intersection counts per experiment). Statistical 
analyses were performed in GraphPad Software Prism 5 using a one-
way analysis of variance followed by Tukey’s multiple comparison test 
as well as Lilliefors normality test followed by two-tailed t test.
Cryo–immuno-EM was performed according to the Tokuyasu 
method (Slot and Geuze, 2007). Cells were initially fixed by 2% para-
formaldehyde and 0.2% glutaraldehyde in 0.1  M PHEM buffer, pH 
7.4. The samples were washed with buffer and embedded in cubes with 
10% gelatin. For cryoprotection, the cells were infiltrated overnight in 
pure 2.3 M sucrose. Blocks were mounted on pins and frozen in N2 liq-
uid. Ultrathin cryosections of 50 nm were cut at −110°C in a cryoultra-
microtome (UC6; Leica Biosystems). The sections were labeled with 
anti-GFP antibody and detected by 15 nm protein A–gold conjugate 
(CMC). Analysis and documentation of the samples were performed at 
80 kV at a transmission electron microscope (Tecnai 12 BioTwin; FEI). 
Selected areas were documented with Ditabis imaging plates.
IP
For IP experiments GFP-tagged ACBD5 and Myc-tagged VAPB were 
expressed in COS-7 cells. After 48 h, cells were washed in PBS and 
then lysed in ice-cold lysis buffer (25 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1% NP-40, 1 mM PMSF, and protease inhibitor cocktail), undis-
solved material was pelleted by centrifugation at 15,000 g, followed 
by a second centrifugation step at 100,000  g.  Clarified lysates were 
then mixed with GFP-TRAP magnetic agarose beads (ChromoTek) 
and incubated for 2  h at 4°C.  Beads were subsequently washed ex-
tensively with lysis buffer and bound proteins eluted with Laemmli 
buffer. Immunoprecipitates and total lysates were analyzed by West-
ern immunoblotting. For in vitro binding assays, GST-VAPBΔTMD 
and MBP-ACBD5ΔTMD constructs were expressed in BL21 Rosetta 
(DE3) cells (EMD Millipore) induced with 1 mM IPTG for 4 h. Cells 
were pelleted by centrifugation at 5,000 g for 10 min and cell pellets 
resuspended in ice-cold E. coli lysis buffer (50 mM Tris-HCl, pH 7.5, 
300 mM NaCl, 0.1% NP-40, 1 mM PMSF, and protease inhibitor cock-
tail). Cells were disrupted by sonication, and the 15,000 g supernatant 
was incubated with GST-TRAP agarose beads (ChromoTek) for 2 h at 
4°C. Beads were then washed extensively with E. coli lysis buffer and 
bound proteins eluted using Laemmli buffer. Immunoprecipitates and 
total lysates were subsequently analyzed by Western immunoblotting.
GFP IP for MS analysis
For GFP IP, 3 × 107 HepG2 cells were transfected with EGFP-rACBD5 
or an EGFP-only vector using polyethyleneimine (PEI) as a transfec-
tion reagent (see fractionation experiments for more details). After 
24  h, transfection efficiency was controlled by fluorescence micros-
copy. If transfection efficiency surpassed 50%, cells were harvested in 
lysis buffer (10 mM Tris/Cl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, and 
2% NP-40) and homogenized by shearing through a syringe and nee-
dle (27G). After 30-min incubation on ice, unsolubilized material was 
removed by centrifugation at 100,000 gav for 30 min at 4°C. Finally, 
the NP-40 concentration of the supernatant was adjusted to 1% using 
dilution buffer (10 mM Tris/Cl, pH 7.5, 150 mM NaCl, and 0.5 mM 
EDTA). In parallel, 75 µl of GFP-TRAP_A slurry (ChromoTek) was 
equilibrated according to the protocol supplied by the manufacturer. 
Subsequently, the GFP-TRAP agarose beads were mixed with the ly-
sates and incubated over night at 4°C on a rotating wheel. Thereafter, 
the lysates were centrifuged at 2,500 gav for 2 min at 4°C and the su-
pernatant discarded. The remaining agarose beads were washed twice 
with dilution buffer containing 1  M NaCl. After a last washing step 
with normal lysis buffer, proteins were eluted from the agarose beads 
by direct incubation in SDS Laemmli buffer.
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Electrophoresis and in-gel digestion for MS
All IP samples (GFP-TRAP) were heated to 95°C for 5 min and cooled 
on ice before loading onto NuPAGE 4–12% Bis-Tris Gels (Thermo 
Fisher Scientific). SDS-PAGE was performed according to the manu-
facturer’s specification. Proteins were fixed within the polyacrylamide 
matrix by incubating the entire gel in 5% acetic acid in 1:1 (vol/vol) 
water/methanol for 30 min. After Coomassie staining (60 min), the gel 
slab was rinsed with water (60 min), and each lane was excised and cut 
from top to bottom into small pieces. Subsequently, the proteins were 
in-gel destained (100 mM ammonium bicarbonate/acetonitrile 1:1 vol/
vol), reduced (10 mM DTT), alkylated (50 mM iodoacetamide), and 
finally trypsin-digested by overnight incubation at 37°C.  The gener-
ated peptides were collected from the gel pieces, which were further 
subjected to a peptide extraction step with an acidic (1.5% formic acid) 
acetonitrile (66%) solution. Both peptide-containing samples were 
combined and dried in a vacuum centrifuge.
MS
Dried peptides were redissolved in 0.1% trifluoroacetic acid and loaded 
on a C18 precolumn (Acclaim; Dionex) using a RSLCnano HPLC sys-
tem (Dionex). Peptides were then eluted with an aqueous-organic gra-
dient, resolved on a C18 column (Acclaim; Dionex) with a flow rate of 
300 nl/min, and electrosprayed into a LTQ Orbitrap XL mass spectrom-
eter (Thermo Fisher Scientific). A Triversa Automate (Advion Biosci-
ences) was used as ion source. Each scan cycle consisted of one Fourier 
transform mass spectrometry full scan and up to seven ion trapping 
mass spectrometry–dependent MS/MS scans of the seven most intense 
ions. Dynamic exclusion (30 s), mass width (10 ppm), and monoiso-
topic precursor selection were enabled. All analyses were performed in 
positive ion mode. Extracted MS/MS spectra were searched against the 
Uniprot/Swissprot database using the PEA KS search engine (Bioinfor-
matics Solutions, Inc.) accepting common variable modifications and 
one missed tryptic cleavage. Peptide tolerance was ±10 ppm, and MS/
MS tolerance was ±0.5 D.
Subcellular fractionation experiments
HepG2 cells were cultivated to 80% confluency in DMEM, low glu-
cose and subsequently transfected with expression plasmids encoding 
Myc-VAPB and EGFP-rACBD5. Cells were transfected with PEI (25 
kD; Polysciences). 1 µg of each plasmid was mixed with a 1 mg/ml 
PEI solution in a ratio 1:5 or mock transfected with a PEI solution 
without DNA. The transfection solution was further diluted in se-
rum-free DMEM (1:8.5) and incubated for 15 min at room tempera-
ture before transfection. 24 h after transfection, HepG2 cells seeded 
on coverslips were withdrawn from the cultures and transfection ef-
ficiency determined by immunofluorescence analysis. In parallel, the 
remaining cells were harvested and centrifuged at 500 gav. A protocol 
to separate and isolate POs from transfected HepG2 cells was de-
veloped by adapting published procedures (Völkl and Fahimi, 1985; 
Islinger et al., 2007). After a washing step with PBS, the HepG2 cell 
pellet was suspended in ice-cold homogenization buffer (250 mM su-
crose, 5 mM MOPS, 1 mM EDTA, 2 mM PMSF, 1 mM DTT, and 
1  mM E-aminocaproic acid, pH 7.4) and cells disrupted by shear-
ing through a syringe and needle (27G). Nuclei and remaining cel-
lular debris were collected by centrifugation at 600 gav for 10 min at 
4°C.  The resulting postnuclear supernatant was subjected to a sec-
ond centrifugation at 2,000 gav for 15 min at 4°C to yield the pellet 
of the “heavy” mitochondrial fraction. The corresponding superna-
tant was centrifuged at 20,000 gav for 20 min at 4°C. The resulting 
PO-enriched pellet of the “light” mitochondrial fraction was resus-
pended in homogenization buffered, overlayed onto a linear Nyco-
denz gradient ranging from 1.14 to 1.19 g/ml density, and centrifuged 
for 3  h at 100,000 gav in a vertical rotor. After centrifugation, 12 
fractions of equal volume were collected and organelles enriched 
by another pelleting step. After determining protein concentration, 
separations were analyzed by immunoblotting applying 5 µg of pro-
tein per lane to the gels.
Statistical analyses
Unless otherwise indicated, a two-tailed, unpaired t test was used to 
determine statistical differences against the indicated group (*, P < 0.05; 
**, P < 0.01; ***, P < 0.001). For quantitative analyses of PO morphol-
ogy (Figs. 5 F and S3), a minimum of 500 cells were examined per 
condition, and organelle morphology was microscopically assessed in at 
least three independent experiments. Data are presented as mean ± SEM.
Online supplemental material
Fig. S1 shows that when ACBD5 is targeted to mitochondria, ER–mito-
chondria interactions are increased. Fig. S2 shows PO–ER associations 
using immunogold EM, that ACBD5–VAPB overexpression increases 
PO–ER interactions in HepG2 cells, and representative electron mi-
crographs for the data shown in Fig. 3 (B and C). Fig. S3 shows that 
mitochondria are unaffected when ACBD5 is silenced in Mff-deficient 
cells and that peroxisomal membrane expansion is reduced when mea-
sured by EM. Fig. S3 also shows that an artificial PO–ER tether re-
stores membrane expansion when ACBD5 is silenced. Video 1 shows 
peroxisomal movement in control fibroblasts. Video 2 shows increased 
peroxisomal movement in fibroblasts silenced for ACBD5. Table S1 
shows plasmids used in this study. Table S2 shows plasmids generated 
in this study. Table S3 shows primers used in this study. Table S4 shows 
siRNAs used in this study. Table S5 shows primary and secondary an-
tibodies used in this study.
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Figure S1. ACBD5 targeted to mitochondria increases mitochondria–ER associations. (A) GFP-ACBD5-MITO is targeted to mitochondria and colocal-
izes with the mitochondrial membrane marker TOM20. Mitochondrial mistargeting of ACBD5 is achieved by mutations in the C-terminal tail region. 
(B) Coexpression of Myc-VAPB and GFP-ACBD5-MITO results in increased association of mitochondria with ER VAPB. (C and D) Higher-magnification view. 
Arrows highlight MITO-ER colocalization. Occasionally, GFP-ACBD5-MITO is still targeted to POs, which are also associated with the ER (arrowheads). 
Note that expression of GFP-ACBD5-MITO alters mitochondrial morphology. Bars: (main) 10 µm; (insets) 2.5 µm.
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Figure S2. ACBD5 and VAPB increase PO–ER association. (A–D) Ultrathin cryosections labeled for GFP protein, detected by 15 nm protein A gold. (A) In 
mock-treated COS-7 cells (stably expressing the PO marker GFP-PTS1), PO profiles can be identified by GFP labeling, which is mainly located in close vi-
cinity to the ER (control). (B–D) In ACBD5–VAPB cotransfected cells, GFP-labeled POs are closely associated with ER membranes and are partially enclosed 
(see arrowheads in D). (D) Higher magnification of dashed area in C. Note the presence of electron-dense material between the ER and PO membranes 
(see Fig. 3). M, mitochondrion. PM, plasma membrane. Bars: (A–C) 200 nm; (D) 50 nm. (E) Representative electron micrographs of PO–ER associations 
in HepG2 cells transfected with control, ACBD5, VAPB, and ACBD5 + VAPB constructs. Note the increased membrane association in cotransfected cells 
(arrowheads). Bars, 200 nm. (F) Quantitative analysis of the mean fraction of PO associated with ER in the different samples. (G) Assessment of the mean 
PO membrane surface in direct contact with ER membrane (see Materials and methods). It should be noted that the number of POs associated with the ER 
in HepG2 cells under control conditions is higher than in COS-7 cells. This may be because of higher metabolic rates and protein turnover in hepatocytes 
compared with fibroblasts and the important role of hepatocytes in lipid metabolism, which is supposed to require metabolic cooperation between POs 
and the ER. (H) Electron micrographs of PO–ER associations in COS-7 cells cotransfected with VAPB and either ACBD5-FFAT or ACBD5-AcB mutants. 
Note the increased membrane association in ACBD5-AcB cotransfected cells (arrowheads), whereas ACBD5-FFAT–transfected cells show no alterations. 
Bars, 200 nm. M, mitochondrion.
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Figure S3. PO membrane extension after ACBD5 knockdown in Mff-deficient fibroblasts can be rescued by expression of an artificial PO–ER tether. (A–C) 
Endogenous ACBD5 associates with PO. Fixed Mff-deficient human skin fibroblasts were labeled with anti-ACBD5 and anti-catalase (peroxisomal marker) 
antibodies. Note that ACBD5 is concentrated at globular POs that give rise to tubular membranes (arrows). (D and E) Silencing of ACBD5 does not impact 
mitochondrial morphology. After siRNA mediated silencing of ACBD5, fixed Mff-deficient human skin fibroblasts were labeled with anti-ACBD5 and anti- 
TOM20 antibodies (mitochondrial marker). Note that ACBD5 silencing is efficient but mitochondrial morphology is not altered. (F–H) Silencing of ACBD5 
reduces PO profile size in Mff-deficient fibroblasts. siRNA-treated cells were fixed and processed for EM and the mean PO membrane circumference of 
unbiasedly sampled PO profiles quantified by intersection counting (see Materials and methods). Electron micrographs of PO profiles in Mff-deficient cells 
treated with control (F) or ACBD5 siRNA (G). Bars, 200 nm. M, mitochondrion. (H) Assessment of the mean PO membrane circumference. Data tested for 
normal distribution by Lilliefors test then analyzed by two-tailed t test; **, P ≤ 0.01. Error bars are SEM from six experiments per condition. (I–S) Expres-
sion of an artificial PO–ER tether restores membrane expansion in ACBD5-silenced Mff-deficient fibroblasts. An artificial PO–ER tether (PO-mRFP-ER) was 
generated based on a previously published MITO-ER tether (Csordás et al., 2006; see Materials and methods). Expression of PO-mRFP-ER in Mff-deficient, 
ACBD5 siRNA-treated fibroblasts restores membrane elongation of PO and results in hyperextension of PO membranes (I–L and Q). Note that some mis-
targeting to mitochondria is also observed (L–N). PO-mRFP-ER colocalizes with ACBD5 in controls (O and P) and promotes PO elongation in the absence 
of ACBD5 (Q and R; R, high intensity to highlight loss of ACBD5). (S) Quantification of PO morphology in controls, ACBD5-silenced cells, and ACBD5- 
silenced cells expressing the PO–ER tether (n = 500, three independent experiments). Data are presented as mean ± SEM. αPEX14, PO marker; α-Tom20, 
mitochondrial marker. Bars, 10 µm.
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Video  1. Loss of ACBD5 increases PO movement. Human fibroblasts were transfected with mock (SV1) or ACBD5 siRNA 
(SV2) and GFP-PTS1 and analyzed by live-cell imaging using an IX81 microscope (Olympus) equipped with a CSUX1 spin-
ning disk head (Yokogawa). 250 stacks of nine planes (0.5 µm thickness, 100 ms exposure) were taken in a continuous 
stream. 125 frames, 10× speed.
Video  2. Loss of ACBD5 increases PO movement. Human fibroblasts were transfected with mock (SV1) or ACBD5 siRNA 
(SV2) and GFP-PTS1 and analyzed by live-cell imaging using an IX81 microscope (Olympus) equipped with a CSUX1 spin-
ning disk head (Yokogawa). 250 stacks of nine planes (0.5 µm thickness, 100 ms exposure) were taken in a continuous 
stream. 125 frames, 10× speed.
Table S1. Plasmids used in this study
Plasmid Source
Myc-VAPB C. Miller, King’s College London, London, England, UK
pETM41 M. Wilmanns, European Molecular Biology Laboratory Hamburg, Hamburg, Germany
EGFP-Sec61β W.A. Prinz, National Institutes of Health, Bethesda, MD
Myc-rACBD5.1 Islinger et al., 2007
EGFP-PTS1 Koch et al., 2005
FLAG-MFF K. Mihara, Kyushu University, Fukuoka, Japan
mAKAP1 (34–63)-mRFP-yUBC6 (MITO–ER linker) G. Hajnoczky, Thomas Jefferson University, Philadelphia, PA
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Table S2. Plasmids generated in this study
Name Template Primers Enzymes Vector
EGFP-ACBD5.1 Myc-rACBD5.1 GFP-ACBD5.1-XhoI-Fw GFP-ACBD5.1-EcoRI-Rv XhoI–EcoRI pEGFP-C1
Myc-ACBD5 HepG2 cDNA Myc-ACBD5 For Myc-ACBD5 Rev EcoRV–XhoI pCMV-3b
FLAG-ACBD5 Myc-ACBD5 — EcoRV–XhoI pCMV-2b
ACBD5_NcoIdel Myc-ACBD5 ACBD5_NcoIdel_F ACBD5_NcoIdel_R
MBP-ACBD5 ACBD5_NcoIdel pETM41_ACBD5_For pETM41_ACBD5_Rev NcoI–KpnI pETM41
MBP-ACBD5ΔTMD MBP-ACBD5 ACBD5_HS_S495X_F ACBD5_HS_S495X_R
MBP-ACBD5 AcB MBP-ACBD5ΔTMD ACBD5_K78A_For ACBD5_K78A_Rev 
ACBD5_Y74F_For ACBD5_Y74F_Rev
MBP-ACBD5 FFAT MBP-ACBD5ΔTMD ACBD5_C302K_For ACBD5_C302K_Rev 
ACBD5_S304E_For ACBD5_S304E_Rev 
ACBD5_Y301K_F ACBD5_Y301K_R
GST-VAPB Myc-VAPB GST_VAPB_F GST_VAPB_R BamHI–NotI pGEX-6p2
GST-VAPBΔTMD GST-VAPB VAPB_220 For VAPB_220 Rev
FLAG-ACBD5-AcB FLAG-ACBD5 ACBD5_K78A_For ACBD5_K78A_Rev 
ACBD5_Y74F_For ACBD5_Y74F_Rev
FLAG-ACBD5 FFAT FLAG-ACBD5 ACBD5_C302K_For ACBD5_C302K_Rev 
ACBD5_S304E_For ACBD5_S304E_Rev 
ACBD5_Y301K_F ACBD5_Y301K_R
EGFP-ACBD5-MITO EGFP-ACBD5 ACBD5_M2SDM_F ACBD5_M2SDM_R
Pex3 (1–44)-RFP-yUBC6 
(PO–ER tether)
mAKAP1 (34–63)-mRFP-yUBC6 — NheI–AgeI First 132 bp of human Pex3 
replacing mAKAP1 (34–63) 
in the MITO–ER tether
Table S3. Primers used in this study
Name Sequence (5′ to 3′)
GFP-ACBD5.1-XhoI-Fw CCG CTC GAG AAA TGG CGG ACA CAC GAT CAG
GFP-ACBD5.1-EcoRI-Rv CCG GAA TTC CGT CAA TTT AGT TTT CTT CTC CTTC
Myc-ACBD5 For AAA GGA TCC ATG CTC TTC CTC TCG TTT CATG
Myc-ACBD5 Rev GTT CTC GAG TTA TCA GTT CAG TTT TCT TCT CCT TCT TTG
ACBD5_NcoIdel_F GTC ATT CCA GTC AAC CTA TGG AAA ATT CTGG
ACBD5_NcoIdel_R CCA GAA TTT TCC ATA GGT TGA CTG GAA TGAC
pETM41_ACBD5_For TCA CCA TGG ACA TGC TCT TCC TCT CGT TTC ATG
pETM41_ACBD5_Rev CCT GGT ACC TCA GTT CAG TTT TCT TCT CCT TCT TTG
ACBD5_HS_S495X_F TCT TGG TGG CCC TTC GAG ATG TGA CCT GGT GTG CTA ACG TTT GC
ACBD5_HS_S495X_R GCA AAC GTT AGC ACA CCA GGT CAC ATC TCG AAG GGC CAC CAA GA
ACBD5_K78A_For GCT TAA ATT TTA TAG CTT CTA TGC GCA GGC AAC TGA AGG ACC CTG
ACBD5_K78A_Rev CAG GGT CCT TCA GTT GCC TGC GCA TAG AAG CTA TAA AAT TTA AGC
ACBD5_Y74F_For GAT GCT TAA ATT TTT TAG CTT CTA TGC GCA GGC
ACBD5_Y74F_Rev GCC TGC GCA TAG AAG CTA AAA AAT TTA AGC ATC
ACBD5_C302K_For TCA GAC AGT GAA GTT TAC AAG GAT TCT ATG GAA CAA TTTG
ACBD5_C302K_Rev CAA ATT GTT CCA TAG AAT CCT TGT AAA CTT CAC TGT CTGA
ACBD5_S304E_For AGT GAA GTT TAC AAG GAT CGT ATG GAA CAA TTT GGA CAAG
ACBD5_S304E_Rev CTT GTC CAA ATT GTT CCA TAC GAT CCT TGT AAA CTT CACT
ACBD5_Y301K_F GAT TCA GAC AGT GAA GTT AAG AAG GAT CGT ATG GAAC
ACBD5_Y301K_R GTT CCA TAC GAT CCT TCT TAA CTT CAC TGT CTG AATC
VAPB_220 For TGG GAA GGA AGA AGG CTA GAG CAC CCG GCT CTT GG
VAPB_220 Rev CCA AGA GCC GGG TGC TCT AGC CTT CTT CCT TCC CA
GST_VAPB_F TCA GGA TCC ATG GCG AAG GTG GAG CAG GT
GST_VAPB_R TTG GGA AGA TTG CCT TGT AGG CGG CCG CATT
ACBD5_M2SDM_F GTA TTT ATA CTA TCA AAG AGC GAG AGC AAA ACT GAA CTG ACT CGAG
ACBD5_M2SDM_R CTC GAG TCA GTT CAG TTT TGC TCT CGC TCT TTG ATA GTA TAA ATAC
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Table S4. siRNAs used in this study
Name Sequence (5′ to 3′) Source
ACBD5 siRNA GCA UUC ACC AAG AUA UAA ATT Ambion (s40666)
VAPB siRNA GCU CUU GGC UCU GGU GGU UUU Eurofins
Pex11β siRNA AUU AGG GUG AGA AUA GAC AGG AUGG Eurofins
Control siRNA si-GEN OME nontargeting siRNA pool #2 GE Healthcare (D-001206-14-05)
Table S5. Primary and secondary antibodies used in this study
Antibodies Type Dilution Source
IMF WB
ACBD5 (HPA012145) pc rb 1:150 1:250 Sigma-Aldrich
ACOX1 pc rb 1:10,000 T. Hashimoto, Shinshu University School of Medicine, Nagano, Japan
ATP synthase mc ms 1:1,000 Abcam
Catalase pc ms 1:150 Abcam
FLAG mc ms 1:500 Sigma-Aldrich
FLAG pc rb 1:750 1:1,000 Sigma-Aldrich
GAP DH mc rb 1:5,000 ProSci
GFP (A11122) pc rb 1:1,000 Thermo Fisher Scientific
Myc (Ab9106) mc rb 1:200 1:1,000 Abcam
Myc (9E10) mc ms 1:200 1:1,000 Santa Cruz Biotechnology, Inc.
PEX14 pc rb 1:1,400 1:4,000 D. Crane, Griffith University, Brisbane, Australia
PEX11β (ab 182100) pc rb 1:1,000 Abcam
PDI mc ms 1:100 Thermo Fisher Scientific
Thioredoxin (ab 179843) mc rb 1:250 OXSD cocktail; Abcam
TOM20 (612278) mc ms 1:200 BD
VAPB pc rb 1:500 Sigma-Aldrich
Alexa Fluor 488 IgG dk anti-rb 1:500 Molecular Probes
Alexa Fluor 488 IgG dk anti-ms 1:400 Molecular Probes
Alexa Fluor 594 IgG dk anti-rb 1:1,000 Molecular Probes
Alexa Fluor 594 IgG dk anti-ms 1:1,000 Molecular Probes
TRI TC IgG dk anti-ms 1:100 Dianova
TRI TC IgG dk anti-rb 1:400 Dianova
HRP IgG gt anti-ms 1:5,000 Bio-Rad Laboratories
HRP IgG gt anti-rb 1:5,000 Bio-Rad Laboratories
dk, donkey; gt, goat; mc, monoclonal; ms, mouse; pc, polyclonal; rb, rabbit.
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